DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • China
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
600436 logo

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Stock Price

SHSE:600436 Community·CN¥73.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

600436 Share Price Performance

CN¥0
-203.20 (-100.00%)
​
CN¥0
-203.20 (-100.00%)
​
Price CN¥0
Thu, 10 Sep 26
Share Pricen/a

600436 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet established dividend payer.

1 Risk
2 Rewards
View Full Analysis

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Key Details

CN¥8.2b

Revenue

CN¥5.3b

Cost of Revenue

CN¥2.9b

Gross Profit

CN¥1.1b

Other Expenses

CN¥1.8b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
3.00
35.58%
22.08%
5.8%
View Full Analysis

About 600436

Founded
1956
Employees
2886
CEO
Jin Ming Huang
WebsiteView website
www.zzpzh.com

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. The company offers traditional Chinese medicines and health products in various forms, including capsule, ointment, tablet, syrup, and pill; health care food and functional drinks; special efficacy cosmetics; and household chemicals under the Pien Tze Huang brand name. It is also involved in the sale of food; production of skin, hair, and oral care daily products; biotechnology and medical device research and development; sale of medical machinery; and online wholesale and retail. The company’s products are used for liver diseases, cardiovascular and cerebrovascular, cancer, cold, dermatology, and other applications. It exports its products. The company was founded in 1956 and is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.

Recent 600436 News & Updates

Recent updates

No updates

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. Competitors

603259 logo

WuXi AppTec

Symbol: SHSE:603259
Market cap: CN¥459.8b
600276 logo

Jiangsu Hengrui PharmaceuticalsLtd

Symbol: SHSE:600276
Market cap: CN¥294.6b
688506 logo

Sichuan Biokin PharmaceuticalLtd

Symbol: SHSE:688506
Market cap: CN¥99.2b
000538 logo

Yunnan Baiyao GroupLtd

Symbol: SZSE:000538
Market cap: CN¥90.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide